CHIPOR Trial: Secondary Debulking and HIPEC in Platinum Sensitive Recurrence
HIPEC combined with cytoreductive surgery significantly improved overall survival and progression-free survival in recurrent ovarian cancer
Shitanshu Uppal
Publications Update # 81
Video summary of CHIPOR trial, study summary of CHIPOR trial
Management of Febrile Neutropenia
GYOEDU Resident: Recurrent Ovarian Cancer
Management of STIC in Patients Undergoing RRSO
Publications Update # 80
Finding time to exercise, Management of STIC, NADINA trial in advanced melanoma, Final OS Keynote A-18, and overtreatment of locally advanced cervical cancer treatment prior to OUTBACK publication
Ovarian Borderline Tumors
GYOEDU Resident: Ovarian Cancer Surveillance and Recurrences
Publications Update # 79
Strategies to overcome workaholism, prevent surgical site infections, and conduct the STOP-IT trial and BALANCE trial to reduce antibiotic duration.
PAOLA-1: Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer (Overall Survival)
Olaparib combined with bevacizumab provided a OS benefit for HRD-positive ovarian cancer patients.